Feds Broaden Big Pharma Bribery Investigation
New York Times:
At least a dozen major drug and device makers are under investigation by federal prosecutors and securities regulators in a broadening bribery inquiry into whether the companies made illegal payments to doctors and health officials in foreign countries.
Read the whole story: New York Times



First Posted: 08/14/10 01:04 AM ET Updated: 05/25/11 06:20 PM ET